HOME >> MEDICINE >> NEWS
Clinical research key in advance to prospective health care

DURHAM, N.C. -- The vast potential of the U.S. health-care system to improve health, minimize disease and increase the value of each dollar spent cannot be realized without a greater emphasis on clinical research, says a Duke University Health System leader.

In an editorial in the Feb. 18, 2004, issue of The Journal of the American Medical Association, Ralph Snyderman, M.D., chancellor for health affairs at Duke University and president and CEO of the Duke University Health System, says scientific evidence is critical to physicians' ability to assess a patient's risk for disease and to offer the most effective treatments to minimize or prevent illness; these are the key elements in a prospective approach to health care. He argues that health care today suffers from a "lack of a robust clinical research enterprise mobilized to translate basic scientific discoveries into clinical relevance," and calls on the medical community to more fully support clinical research and clinical researchers.

The editorial complements a report by researchers at the National Institutes of Health's Center for Scientific Review examining the role of the NIH as a potential barrier to clinical investigation. The study found that although physicians compete favorably for grants in the peer-review process, funding rates for clinical research lagged behind those for non-clinical research.

"Clinical research -- including the translation of basic scientific findings into medical treatments and the evaluation of patient outcomes -- is the critical element needed to define and monitor effective health strategies," Snyderman said. "Without clinical research, the rational application of research discoveries to the development of prospective care and personalized health planning cannot occur."

In the "prospective health care" model advocated by Duke Health System leadership, physicians would use rapidly evolving tools to determine an individual's specific risk fo
'"/>

Contact: Jeff Molter
molte001@mc.duke.edu
919-684-4148
Duke University Medical Center
17-Feb-2004


Page: 1 2

Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial of Etanercept for Wegeners disease shows no benefit
3. Clinical trial participants fare no better, no worse than other patients
4. Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys
5. National Academies news: Clinical research involving children
6. Clinical trial of new TB vaccine begins
7. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
8. Clinical factors useful to identify heart failure patients with high risk of death
9. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
10. $7 million grant continues Asthma Clinical Research Network efforts
11. Clinical study of Penn State Hershey technology begins in South Africa

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Clinical research key advance prospective health care

(Date:5/24/2013)... 24, 2013 DiaperBuys.com is pleased to ... Contest. Lindsey Willis of Olathe, Kansas, won the grand ... DiaperBuys. Second prize was a three-month supply of Cuties ... Vegas, Nev.; and third prize, a one-month supply, went ... was run through the company’s Facebook page. Entrants uploaded ...
(Date:5/24/2013)... Scott Ryan Tischler of Tischler Brothers Fitness recently ... of fat in just over a year. Not only ... importance of exercising. Scott also taught Troy the importance ... rules of healthy eating and having a regular exercise ... 1.    Find a distraction when a food craving attacks. Pushups ...
(Date:5/23/2013)... May 23, 2013 Over the past ... gradually transforming, which has affected the Medical Group ... and seeking regular hours, more young physicians are opting ... other medical groups,” says IBISWorld industry analyst Anna Son. ... pressure, a number of older physicians are selling their ...
(Date:5/23/2013)... 23, 2013 Whether working in an ... and law enforcement need an added layer of protection ... Night VISER , is an effective portable, rugged, ... system to increase border and perimeter security. , Today, ... more than tripled over the past three years, with ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Vegas ... is pleased to announce all new vacation packages ... in coming to Las Vegas for this patriotic ... it is thanks to VegasHotelEscapes.com's new special pricing ... to state that it guarantees the lowest prices ...
Breaking Medicine News(10 mins):Health News:DiaperBuys.com Announces Photo Contest Winners 2Health News:Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 2Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 3
(Date:5/24/2013)... China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or ... in China , today announced that ... issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai ... that on May 21, 2013, Ms. Siu ... shareholders of the Company, and her spouse, Mr. Tung ...
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... will participate in the Deutsche Bank Health Care Conference ... Waterfront Hotel.  Mr. Adrian Adams , ... an overview of the Company and its product pipeline ...   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/24/2013)... YORK , May 24, 2013 In accordance ... Rules and Rule 14e-1 of the United States Exchange Act, ... its original offer for Elan Corporation (NYSE: ELN). ... Limited ("Royalty Pharma") made an offer for the entire of ... Corporation, plc ("Elan") (the "Original Offer").  On ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9
Cached News: